Literature DB >> 18794535

Perioperative or adjuvant therapy for resectable colorectal hepatic metastases.

Nicholas J Petrelli.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18794535     DOI: 10.1200/JCO.2008.18.5868

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Resectability of initially unresectable liver metastases from colorectal cancer should not be the primary end point of clinical trials.

Authors:  Alberto Sobrero; Giuseppe Aprile
Journal:  Gastrointest Cancer Res       Date:  2009-01

2.  Resectable colorectal liver metastases: optimal sequencing of chemotherapy.

Authors:  Terence C Chua; David L Morris
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.

Authors:  Thomas A Aloia; Giuseppe Zimmitti; Claudius Conrad; Vijaya Gottumukalla; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Surg Oncol       Date:  2014-05-21       Impact factor: 3.454

Review 4.  The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  J Gastrointest Cancer       Date:  2016-12

Review 5.  Multidisciplinary approach of colorectal liver metastases.

Authors:  I Juez; C Rubio; J Figueras
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

Review 6.  Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis.

Authors:  Wei Liu; Yi Sun; Lei Zhang; Bao-Cai Xing
Journal:  Int J Colorectal Dis       Date:  2015-07-23       Impact factor: 2.571

7.  Management of potentially resectable colorectal cancer liver metastases.

Authors:  Fausto Meriggi; Paola Bertocchi; Alberto Zaniboni
Journal:  World J Gastrointest Surg       Date:  2013-05-27

8.  Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Authors:  Ninos Ayez; Zarina S Lalmahomed; Alexander M M Eggermont; Jan N M Ijzermans; Jeroen de Jonge; Kees van Montfort; Cornelis Verhoef
Journal:  Ann Surg Oncol       Date:  2011-10-18       Impact factor: 5.344

9.  Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.

Authors:  Ninos Ayez; Eric P van der Stok; Hans de Wilt; Sandra A Radema; Richard van Hillegersberg; Rudi M Roumen; Gerard Vreugdenhil; Pieter J Tanis; Cornelis J Punt; Cornelis H Dejong; Rob L Jansen; Henk M Verheul; Koert P de Jong; Geke A Hospers; Joost M Klaase; Marie-Cecile Legdeur; Esther van Meerten; Ferry A Eskens; Nelly van der Meer; Bruno van der Holt; Cornelis Verhoef; Dirk J Grünhagen
Journal:  BMC Cancer       Date:  2015-03-26       Impact factor: 4.430

10.  Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy.

Authors:  Da Xu; Xiao-Feng Liu; Xiao-Luan Yan; Kun Wang; Bao-Cai Xing
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.